Short Description
The PerkinElmer Operetta CLS is an innovative high-content/high-throughput analysis system with a confocal option. The device is specialized in obtaining more physiologically relevant information through complex image analyses at high throughput.
The unique features of the PerkinElmer Operetta CLS™ are diverse and include, among other things, an excitation spectrum equipped with 8 LEDs covering a range from UV to near-infrared, a 4-position emission filter wheel, and three water-immersion objectives (20x, NA 1.0; 40x, NA 1.1; 63x, NA 1.15), which enable higher Z-resolution for 3D analyses as well as shorter measurement times.
Furthermore, the system is controlled by Harmony, a user-friendly software platform, and plate data can be automatically transferred to the PerkinElmer Columbus image storage and analysis system.
Contact Person
Doris Wilflingseder
Research Services
Automated imaging of large numbers of sample; quantitative analysis of cellular phenotypes from fluorescence, brightfield, or phase-contrast images; suitable for siRNA/CRISPR screens, or drug discovery studies; assistance in confocal / widefield / brightfield / phase-contrast imaging; assistance in multi-color fluorescence imaging
Methods & Expertise for Research Infrastructure
Using the PerkinElmer Operetta CLS, we perform high-content, high-throughput imaging and quantitative analysis of complex 3D tissues and organoids. The system’s confocal capabilities and water-immersion objectives enable high-resolution 3D reconstruction and detailed phenotypic characterization. We conduct automated test series and compound screenings in multiwell formats, as well as functional live-cell analyses, including mucociliary clearance assays and dynamic cellular response measurements under physiologically relevant conditions.
Ignaz Semmelweis Institute
Uni Vienna: Molecular Drug Targeting Lab
Med Uni Innsbruck: Hygiene and Medical Microbiology
Med Uni Graz
Davison G, Schoeman M, Chidley C, Dulson DK, Schweighofer P, Witting C, Posch W, Matta GG, Consoli C, Farley K, McCullough C, Wilflingseder D. ColdZyme® reduces viral load and upper respiratory tract infection duration and protects airway epithelia from infection with human rhinoviruses. J Physiol. 2025 Mar;603(6):1483-1501. doi: 10.1113/JP288136. Epub 2025 Feb 28. PMID: 40019230; PMCID: PMC11908491.
